Immunoadsorption Therapy in Guillain-Barré Syndrome
- 31 July 1998
- journal article
- case report
- Published by Elsevier in Pediatric Neurology
- Vol. 19 (1) , 55-57
- https://doi.org/10.1016/s0887-8994(98)00010-1
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health and Welfare (07671278)
This publication has 14 references indexed in Scilit:
- Cranial polyneuropathy with elevated serum antiganglioside antibodyPediatric Neurology, 1997
- Campylobacter jejuni infections and anti‐GM1 antibodies in guillain‐barré syndromeAnnals of Neurology, 1996
- Immunopathogenesis and treatment of the guillain–barré syndrome—part IIMuscle & Nerve, 1995
- Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain‐Barré syndrome and controls: Correlation and prognosisAnnals of Neurology, 1993
- The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain‐Barré syndrome and in other neuroimmunological disordersAnnals of Neurology, 1993
- Campylobacter jejuni strains from patients with guillain‐barré syndrome belong mostly to penner serogrpup 19 and contain β‐N‐acetylglucosamine residuesAnnals of Neurology, 1993
- Adsorption therapy with tryptophan-conjugated polyvinyl alcohol gels in 10 patients with acute Guillain-Barré syndromeTransfusion Science, 1993
- Cross-reactive antigen between nervous tissue and a bacterium elicits Guillain-Barré syndrome: Molecular mimicry between ganglioside GM1, and lipopolysaccharide from Penner’s serotype 19 of Campylobacter jejuni Biomedical Research, 1992
- Anti-GM1 antibodies in patients with Guillain-Barre syndrome.Journal of Neurology, Neurosurgery & Psychiatry, 1992
- Acute axonal polyneuropathy associated with anti‐GM 1 antibodies following Campylobacter enteritisNeurology, 1990